Sign Out
Hypersensitivity to the active substance or to any of the excipients in the formula.
Second and third trimester of pregnancy.
Biliary obstructive disorders.
Severe hepatic impairment.
The concomitant use of telmisartan with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m2).
